ABA Centers of America, a rapidly expanding multi-state autism therapy provider headquartered in Fort Lauderdale, Florida, has acknowledged that it is the subject of an intensive federal criminal investigation regarding its healthcare billing practices. The enterprise, which experienced a meteoric rise following its launch in 2020, is currently cooperating with federal investigators while simultaneously fighting off high-stakes civil litigation from major insurance providers and corporate entities alleging large-scale healthcare fraud and racketeering schemes.
The scrutiny surrounding the organization underscores growing regulatory and legal oversight within the burgeoning behavioral health sector. As federal authorities examine internal communications, financial transactions, and corporate billing architecture, the fallout has already reached elite academic institutions, disrupting major philanthropic agreements and prompting widespread industry reflection on rapid corporate scaling in specialized medicine.
Federal Scrutiny and Affidavits Reveal Allegations
The federal investigation into ABA Centers of America became public knowledge following the disclosure of an extensive 81-page federal affidavit submitted to a magistrate judge in New Hampshire. The document outlines an ongoing inquiry led by prosecutors from the fraud section of the U.S. Justice Department’s criminal division in Washington, working in tandem with the U.S. Attorney’s Office in Concord, New Hampshire, and the U.S. Department of Health and Human Services.
According to court filings, federal agents secured judicial permission early in 2025 to search the electronic communications and Microsoft email accounts of founder Christopher M. Barnett and several top-tier company executives. Prosecutors are investigating potential offenses that include false statements relating to healthcare matters, wire fraud, healthcare fraud, conspiracy to commit money laundering, and transacting in criminal proceeds. While no formal criminal charges have been filed against the company or any individuals to date, the breadth of the warrant reflects a comprehensive examination of the firm’s administrative and financial operations.
The affidavit details specific billing discrepancies, alleging that ABA Centers of America and an affiliated billing arm systematically submitted fraudulent claims to healthcare benefit programs. Investigators assert that the organization billed for medically unnecessary services or services purportedly rendered in the District of Massachusetts, the District of New Hampshire, and other jurisdictions by misrepresenting the place of service, the rendering provider, and medical necessity.
Investigators allege that the company billed for non-treatment activities—such as periods when young patients were sleeping or watching television—and structured its therapy recommendations around an internal rating system designed to maximize profit margins based on a patient’s health insurance coverage. Furthermore, interviews with former employees and patients revealed that services rendered in Massachusetts were allegedly billed under New Hampshire geographical designations to capitalize on higher insurance reimbursement rates prevalent in the latter state.
Chronology of Growth, Scrutiny, and Legal Battles
The trajectory of ABA Centers of America traces a path from a regional startup to a national contender, followed by mounting legal friction:
- 2020: Christopher M. Barnett founds ABA Centers of America, laying the groundwork for a multi-state enterprise under the parent organization ICBD Holdings, headquartered at 110 E. Broward Blvd. in Fort Lauderdale, Florida.
- 2022: The company expands its clinical footprint into Florida under the banner of ABA Centers of Florida, opening locations in Port St. Lucie, Jensen Beach, Tamarac, Boca Raton, West Palm Beach, and Orlando.
- 2024: The company achieves national recognition, ranking No. 5 on the Inc. 5000 list of fast-growing private companies, supported by a workforce exceeding 2,000 employees across more than 10 states.
- Early 2025: The U.S. Department of Health and Human Services initiates its federal inquiry in New Hampshire, culminating in court-approved searches of executive communications.
- October 2025: Temple University announces a landmark $55 million philanthropic pledge from Barnett for its College of Public Health, prompting the university to rename the institution in his honor.
- Late 2025: Civil litigation initiated by Publix Super Markets and Point32Health subsidiaries (Harvard Pilgrim Health Care) intensifies, with federal and state courts advancing multi-million-dollar counterclaims alleging systemic insurance fraud and racketeering.
- September 2026: Temple University rescinds the naming rights and terminates the $55 million pledge following revelations of the federal investigation, citing a mutual agreement.
Concurrent Civil Litigation and Insurance Claims
In addition to the federal criminal inquiry, ABA Centers of America faces complex civil litigation initiated by major health plans and commercial entities. The disputes center on allegations of inflated billing models that manipulate insurance reimbursement calculations.
The legal battle with Publix Super Markets and its group health benefits plan originated in Florida state court when ABA sued for millions in allegedly unpaid claims. Publix responded by filing a federal countersuit in the Middle District of Florida—later transferred to the Southern District of Florida under U.S. District Judge Raag Singhal—seeking approximately $15 million in damages under the Racketeer Influenced and Corrupt Organizations (RICO) Act.
Judge Singhal allowed six of nine counts in the Publix lawsuit to proceed, noting in an August order that the civil action describes a mechanism where healthcare providers submitted artificially inflated bills. According to the plaintiffs, the company intended for insurers to calculate payouts based on these inflated totals while collecting little to no out-of-pocket coinsurance from plan members, thereby causing employers and insurance plans to bear a disproportionate financial burden.
Similar litigation persists in Massachusetts state court, where Harvard Pilgrim Health Care and Point32Health subsidiaries filed an amended counterclaim against ABA Centers and Integrative Healthcare Services, seeking upwards of $19 million for an alleged scheme to defraud health plans.
Philanthropic Fallout and Academic Reversal
The convergence of legal challenges has impacted the public profile of founder Christopher M. Barnett. Most notably, Temple University in Philadelphia walked away from a historic $55 million donation pledged by Barnett in October 2025. In recognition of the gift, the university had renamed its College of Public Health the Christopher M. Barnett College of Public Health.
However, in a campus-wide communication issued by Temple President John Fry and Board Chair Mitchell L. Morgan, the university announced that it had mutually agreed with Barnett to terminate the philanthropic commitment. Administrators confirmed that no funds had been transferred toward the pledge prior to its cancellation, and references to Barnett’s name on the college have been removed.
University leadership noted in their statement that Barnett strenuously denied any wrongdoing and was managing a serious medical issue. Neither company representatives nor institutional spokespeople have provided further updates regarding Barnett’s current executive status or health condition.
Company Response and Operational Defense
In response to inquiries regarding the federal probe, Maria Isina Areco, director of public relations for ABA Centers and ICBD Holdings, issued an official statement emphasizing cooperation with authorities.
"We are aware that the federal government is investigating the company," Areco stated. "We are working with federal investigators and will respond at the appropriate time."
The company characterized its business operations as intentionally disruptive to traditional healthcare delivery models. "We always knew that our business model is disruptive to the status quo and upends current business models for both providers and payors," the statement read. "It is also important to note that this investigation does not appear to be focused on the quality of the care that we provide."
ABA Centers defended its clinical framework, emphasizing its mission to eliminate extensive waiting lists for families seeking autism services. The organization maintained that its treatment plans are individualized, data-driven, and science-backed, noting that care specifications are established by licensed clinicians and authorized by health insurance providers prior to service delivery.
Broader Industry Implications and Future Outlook
The legal and regulatory challenges facing ABA Centers of America highlight broader structural tensions within the specialized behavioral health sector. As the prevalence of autism spectrum disorder diagnoses increases nationwide, venture capital and private equity investments have flowed heavily into applied behavior analysis (ABA) therapy providers, driving rapid multi-state expansion and commercial scaling.
Legal analysts and healthcare compliance experts suggest that the intersection of rapid growth, complex multi-state insurance billing regulations, and high reimbursement rates creates substantial compliance vulnerabilities. Providers operating across multiple jurisdictions must navigate disparate state-level mandates, utilization management policies, and insurance guidelines, elevating the risk of administrative scrutiny.
As the federal criminal investigation continues alongside active civil proceedings in Florida and Massachusetts, the outcome of these legal actions is expected to establish important precedents regarding billing transparency, corporate governance, and compliance oversight within private equity-backed healthcare enterprises. ABA Centers of America maintains that it continues to refine its compliance protocols, staff documentation practices, and clinical training programs as it addresses the ongoing inquiries.
